Stocks

McDonald’s Non-GAAP EPS of $2.95 Beaten Expectations by $0.12, but Revenue of $6.41 Billion Missed Them by $40 Million

 Stocks

McDonald’s just released its quarterly earnings numbers, which appeared somewhat softer than anticipated, pushing its stock moderately down in the U.S. premarket as of February 5.

February 5, 2024

views 1237
McDonald's Delivers Strong Quarterly Results, Promises to Increase Dividend by 10 Percent

McDonald's Delivers Strong Quarterly Results, Promises to Increase Dividend by 10 Percent

Investors were positively surprised with McDonald's (MCD) Q3 2023 financial results, with the company doing well on both top and bottom lines thanks to global sales growth.

October 30, 2023

views 1254
Intel and Colgate-Palmolive Posted Extremely Weak Earnings Results, While Tesla and Chevron Bested Forecasts

Intel and Colgate-Palmolive Posted Extremely Weak Earnings Results, While Tesla and Chevron Bested Forecasts

U.S. stocks are headed for another lukewarm week after yesterday’s strong rebound.

January 27, 2023

views 1470
China’s Economy Grew by 3.9 Percent in Q3 2022

China’s Economy Grew by 3.9 Percent in Q3 2022

U.S. stock futures rose Sunday evening after all three major averages notched their best week since June at Friday's close.

October 24, 2022

views 1502

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2969
Cryptocurrencies

Elon Musk's Tesla has Added a Dogcoin (DOGE) Payment Form to its Website. The Meme Coin Soars.

May 6, 2024

views 2963
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2882
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2865
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2816
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.